Search

everythinglearnresearchcommunity

for

Search:↓

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

The document lists various dermatology topics, treatments, and diagnostic methods.

Seborrheic dermatitis significantly lowers quality of life, especially in young people, women, and those with higher education.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

Finasteride improves hair growth in men with androgenetic alopecia.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Current treatments for alopecia show no significant long-term benefits.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

The study suggests pandemic stress might worsen or trigger hair loss problems.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.